2014 annual financial data
CytomX Therapeutics 2014 Net margin
CytomX Therapeutics 2014 net margin with verified reported values.
Direct answer
Net margin was -597.01%.
Operating income was -29,765,000 USD and net income was -30,310,000 USD.
Operating cash flow was 31,802,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,077,000 USD
- Operating income
- -29,765,000 USD
- Net income
- -30,310,000 USD
- Operating cash flow
- 31,802,000 USD